Metastat - Dividend History | MTST
Historical dividend payout and yield for Metastat (MTST) since 1971. The current TTM dividend payout for Metastat (MTST) as of December 31, 1969 is $0.00. The current dividend yield for Metastat as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$0.000B |
$0.000B |
|
MetaStat, Inc. is a life science company focused on understanding and treating systemic metastasis. The Company's portfolio is comprised of two diagnostic assets - MetaSite(TM) and MenaCalc(TM) and a therapeutic platform - MenaBloc(TM). Its MetaSite Breast(TM) and MenaCalc(TM) diagnostic product lines are designed to predict the probability of cancer metastasizing and MenaBloc therapeutics to reduce or eliminate metastasis. MetaStat, Inc. is headquartered in Montclair, New Jersey.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
